A PHASE 1, RANDOMIZED, OPEN-LABEL, 4-PERIOD, 5-TREATMENT, 6-SEQUENCE, CROSSOVER, SINGLE-DOSE STUDY IN HEALTHY PARTICIPANTS TO INVESTIGATE THE EFFECT OF TABLET FORMULATION AND FOOD ON THE BIOAVAILABILITY OF PF-07104091
Phase: PHASE1
Conditions: Healthy
Sponsor: Pfizer

CCI

CCI

CCI

CCI

CCI
CCI

CCI
CCI
CCI
CCI
CCI
CCI
CCI
CCI

CCI
CCI
CCI
CCI
CCI

CCI

CCI
CCI

CCI
CCI
CCI
CCI
CCI
CCI
CCI
CCI
CCI

CCI
CCI
CCI
CCI
CCI

CCI
CCI
CCI
CCI
CCI
CCI

CCI
CCI
CCI
CCI
CCI

CCI
CCI

CCI
CCI
CCI
CCI
CCI
CCI
C
CI
CCI
C
CI
CCI
CCI
CCI
CCI
CCI
CCI

CCI
CCI
CCI
CCI
C
CI
CCI
C
CI
CCI
CCI
CCI

CCI

CCI

CCI

CCI

CCI

CCI

CCI

CCI